Development of operational immunologic tolerance with neonatal gene transfer in nonhuman primates: preliminary studies

Gene Therapy
D S TaiG S Lipshutz

Abstract

Achieving persistent expression is a prerequisite for effective genetic therapies for inherited disorders. These proof-of-concept studies focused on adeno-associated virus (AAV) administration to newborn monkeys. Serotype rh10 AAV expressing ovalbumin and green fluorescent protein (GFP) was administered intravenously at birth and compared with vehicle controls. At 4 months postnatal age, a second injection was administered intramuscularly, followed by vaccination at 1 year of age with ovalbumin and GFP. Ovalbumin was highest 2 weeks post administration in the treated monkey, which declined but remained detectable thereafter; controls demonstrated no expression. Long-term AAV genome copies were present in myocytes. At 4 weeks, neutralizing antibodies to rh10 were present in the experimental animal only. With AAV9 administration at 4 months, controls showed transient ovalbumin expression that disappeared with the development of strong anti-ovalbumin and anti-GFP antibodies. In contrast, increased and maintained ovalbumin expression was noted in the monkey administered AAV at birth, without antibody development. After vaccination, the experimental monkey maintained levels of ovalbumin without antibodies, whereas controls demonstra...Continue Reading

References

Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·B D Jamieson, R Ahmed
Apr 15, 1995·Transplantation·N Chen, E H Field
Feb 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·K M GarzaK S Tung
Oct 6, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·G S LipshutzK M Gaensler
Sep 8, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·R W HerzogC D Lothrop
Sep 8, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·P A FieldsK A High
Jan 10, 2002·Immunological Reviews·R E Bontrop
Jul 5, 2002·Seminars in Thrombosis and Hemostasis·Jean-Marie R Saint-Remy
Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Javier Mestas, Christopher C W Hughes
Feb 26, 2005·Blood·Guillaume Darrasse-JèzeDavid Klatzmann
Jun 21, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alice F TarantalDonald B Kohn
Jan 13, 2009·The Journal of Infectious Diseases·Roberto CalcedoJames M Wilson
Apr 16, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Chia-Ling GauGerald S Lipshutz
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mark L BrantlyTerence R Flotte
Sep 25, 2009·Molecular Genetics and Metabolism·Priya S KishnaniY-T Chen
Jul 28, 2010·The New England Journal of Medicine·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Sep 17, 2010·Nature·Marina Cavazzana-CalvoPhilippe Leboulch
Nov 4, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Manuel GrezAdrian J Thrasher
Dec 2, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lauren E Mays, James M Wilson
Jan 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Chuhong HuGerald S Lipshutz
Apr 27, 2011·Human Molecular Genetics·Barry J ByrneCathryn S Mah
May 11, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yu Fu WangHua-Ping Liang
Aug 4, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lili WangJames M Wilson
Dec 14, 2011·The New England Journal of Medicine·Amit C NathwaniAndrew M Davidoff
Feb 11, 2012·Science Translational Medicine·Jean BennettAlbert M Maguire
May 4, 2012·Science Translational Medicine·John SchollerCarl H June
Jul 5, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Eun K LeeGerald S Lipshutz
May 29, 2014·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Cynthia A BatchelderAlice F Tarantal

❮ Previous
Next ❯

Citations

Sep 7, 2019·Autism Research : Official Journal of the International Society for Autism Research·Mark J Zylka
Jul 18, 2018·Nature Medicine·Giulia MassaroAhad A Rahim

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.